New policy brief highlights importance of early type 1 diabetes detection

Type 1 diabetes is an autoimmune condition that requires lifelong insulin therapy. Its global impact continues to rise, with more than 9 million people living with the condition. Delayed diagnosis postpones essential treatment and poses serious health risks. A new policy brief by the International Diabetes Federation (IDF) and the International Society for Pediatric and Adolescent Diabetes (ISPAD) provides advocates, healthcare professionals and policymakers with recommendations to advance type 1 diabetes screening and early diagnosis. The IDF-ISPAD policy brief: Highlights the impact of type 1 diabetes worldwide. Underscores the severity and potentially life-threatening consequences of a late type 1 diabetes diagnosis. Showcases the latest techniques to screen and potentially delay the progression of type 1 diabetes. Provides policy recommendations to improve screening and early diagnosis of type 1 diabetes. Shares lived experiences of living with type 1 diabetes from different regions.